GSK Investigational Site

Wonju-si, Gangwon-do 220-701

0 studies enrolling now · 2 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease — Completed